- CANCER HELPLINE: 1800-22-1951
- 91 7317418888
- contact@drharshatreya.com
- CANCER HELPLINE: 1800-22-1951
Gallbladder cancer is a rare type of cancer that originates in the gallbladder, a small, pear-shaped organ located beneath the liver. The gallbladder stores bile, a digestive fluid produced by the liver that helps break down fats. Gallbladder cancer is often difficult to detect in its early stages because the gallbladder is hidden behind the liver, and early symptoms can be vague or absent. By the time it is diagnosed, the cancer may have already spread to other areas.
Sometimes the cancer does not spread any further. This is called “in situ.” If the cancer spreads outside the breast, the cancer is called “invasive.” It may just spread to nearby tissues and lymph nodes. Or the cancer may metastasize (spread to other parts of the body) through the lymph system or the blood.
Chennai.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit,
Genetic Mutations: ALL often results from genetic mutations that occur in the DNA of white blood cells, specifically lymphocytes. These mutations cause cells to grow and divide uncontrollably, eventually crowding out healthy blood cells. While the mutations are typically random, they can be influenced by certain risk factors.
Inherited Conditions: Certain genetic syndromes, like Down syndrome or Li-Fraumeni syndrome, are associated with a higher risk of ALL due to pre-existing DNA abnormalities.
Environmental Factors: While not directly proven, some studies suggest that exposure to high levels of radiation, specific chemicals (like benzene), and previous cancer treatments (chemotherapy or radiation) may increase the likelihood of developing ALL.
Age and Gender: ALL is more common in children, especially those aged 3-5 years, though adults can also develop the disease. Males are generally at a slightly higher risk than females.
Infections in Early Life: Although still under study, some research suggests that certain infections during infancy might contribute to a higher risk of ALL, possibly due to immune system activation.
ALL is a rapidly progressing disease, but with modern treatments, many patients achieve remission. Treatment plans are customized based on age, health, and disease stage.
Chemotherapy: Chemotherapy is the cornerstone treatment for ALL. A combination of drugs is used to kill cancer cells throughout the body. This treatment usually occurs in multiple phases, including induction (to achieve remission), consolidation (to destroy any remaining cancer cells), and maintenance therapy (to prevent recurrence).
Targeted Therapy: For patients with specific genetic markers, targeted drugs can be used to attack leukemia cells directly while sparing healthy cells. Examples include tyrosine kinase inhibitors (like imatinib) for patients with the Philadelphia chromosome, a specific genetic mutation linked to ALL
Radiation Therapy: Radiation is less commonly used but may be applied in cases where ALL has spread to the brain or spinal cord.
Stem Cell Transplant: For high-risk cases or when standard treatments are less effective, a stem cell transplant may be considered. This procedure involves replacing the patient’s bone marrow with healthy stem cells from a donor, allowing the body to produce new, healthy blood cells.
Immunotherapy: CAR T-cell therapy is an emerging treatment that involves modifying a patient’s immune cells to recognize and destroy leukemia cells. It is highly promising, especially for relapsed cases.
© 2024 Harshvardhan Atreya. All Rights Reserved.